The fact
The deal includes debt and values the assets at $1.71 billion.
This divestment refocuses the company on pharmaceutical and biotech solutions.
Click the link to read an article on the topic:
The deal includes debt and values the assets at $1.71 billion.
This divestment refocuses the company on pharmaceutical and biotech solutions.